Abstract
1/2020
vol. 15
Special paper
Guidelines for Clostridium difficile infection in adults
- Department of Internal Medicine and Geriatrics, Jagiellonian University Medical College, Krakow, Poland
- Department of Endoscopy, University Hospital, Krakow, Poland
- Department of Gastroenterology and Hepatology, Medical University of Gdansk, Gdansk, Poland
- Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland
- Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Krakow, Poland
- Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Postgraduate Education Centre, Warsaw, Poland
- Department of Gastrointestinal Oncology, "Maria Sklodowska-Curie" Clinical Oncology Institute, Warsaw, Poland
- Central Clinical Hospital of Ministry of Inferior and Administration, Warsaw, Poland
- Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2020; 15 (1): 1–21
Online publish date: 2020/03/19
Clostridium difficile infection (CDI) has become a serious medical and epidemiological problem, especially in well developed countries. There has been evident increase in incidence and severity of CDI. Prevention, proper diagnosis and effective treatment are necessary to reduce the risk for the patients, deplete the spreading of infection and diminish the probability of recurrent infection. Antibiotics are the fundamental treatment of CDI. In patients who had recurrent CDI fecal microbiota transplantation seems to be promising and efficient strategy. These guidelines systematize existing data and include recent changes implemented in the management of CDI.
Keywords
Clostridium difficile infection, pseudomembranous colitis, diarrhea, antibacterial treatment, fecal microbiota transplantation
Coverage in
Integrated with


